Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Ajanta Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)more...
Clarification on News Item Appearing in Reutersmore...
Ajanta Pharma Limited has informed the Exchange about Formation of Subsidiary in Irelandmore...
Pls find enclosed herewith Intimation w.r.t Formation of Subsidiarymore...
Ajanta Pharma Limited has informed the Exchange about Schedule of meetmore...
Pls find enclosed Investor Call Intimationmore...
As of December 2025 66.25% is owned by Indian Promoters and 33.75% by Public. Institutional holds 26.55% (Insurance Companies 2.65%) and Non-Institut...more...
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to conside...more...
Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Pls find enclosed Certificate as per Reg. 74(5) of SEBI (DP) Regulations 2018.more...
Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 20...more...
Ajanta Pharma Limited has informed the Exchange regarding a press release dated December 23 2025 titled Press Release .more...
PFA Press Releasemore...
Ajanta Pharma Limited has informed the Exchange about Transcriptmore...
Pls find enclosed Written Transcript of Earnings Callmore...
Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...
Ajanta Pharma Ltd. on Friday 24 October 2025 has announced Interim dividend of 1400 percent on Equity Share to its shareholders holding shares on the...more...
Ajanta Pharma Limited has informed the Exchange about Link of Recordingmore...
PFA Audio recording of Earnings call conducted on 3rd November 2025more...
Ajanta Pharma Limited has informed the Exchange regarding change in Registered Office of the company.more...
BOARD MEETINGS Company Name : Aarti Industries Date : 02-02-2026